Imaging characteristic of dual-phase (18)F-florbetapir (AV-45/Amyvid) PET for the concomitant detection of perfusion deficits and beta-amyloid deposition in Alzheimer's disease and mild cognitive impairment
- PMID: 27003417
- DOI: 10.1007/s00259-016-3359-8
Imaging characteristic of dual-phase (18)F-florbetapir (AV-45/Amyvid) PET for the concomitant detection of perfusion deficits and beta-amyloid deposition in Alzheimer's disease and mild cognitive impairment
Abstract
Purpose: We investigated dual-phase (18)F-florbetapir (AV-45/Amyvid) PET imaging for the concomitant detection of brain perfusion deficits and beta-amyloid deposition in patients with Alzheimer's disease (AD) and amnestic mild cognitive impairment (MCI), and in cognitively healthy controls (HCs).
Methods: A total of 82 subjects (24 AD patients, 44 MCI patients and 14 HCs) underwent both dual-phase (18)F-AV-45 PET and MRI imaging. Dual-phase dynamic PET imaging consisted of (1) five 1-min scans obtained 1 - 6 min after tracer injection (perfusion (18)F-AV-45 imaging, pAV-45), and (2) ten 1-min scans obtained 50 - 60 min after tracer injection (amyloid (18)F-AV-45 imaging). Amyloid-negative MCI/AD patients were excluded. Volume of interest analysis and statistical parametric mapping of pAV-45 and (18)F-AV-45 images were performed to investigate the perfusion deficits and the beta-amyloid burden in the three study groups. The associations between Mini-Mental State Examination (MMSE) scores and global perfusion deficits and amyloid deposition were investigated with linear and segmental linear correlation analyses.
Results: HCs generally had normal pAV-45 findings, whereas perfusion deficits were evident in the hippocampus, and temporal, parietal and middle frontal cortices in both MCI and AD patients. The motor-sensory cortex was relatively preserved. MMSE scores in the entire study cohort were significantly associated with the degree of perfusion impairment as assessed by pAV-45 imaging (r = 0.5156, P < 0.0001). (18)F-AV-45 uptake was significantly higher in AD patients than in the two other study groups. However, the correlation between MMSE scores and (18)F-AV-45 uptake in MCI patients was more of a binary phenomenon and began in MCI patients with MMSE score 23.14 when (18)F-AV-45 uptake was higher and MMSE score lower than in patients with early MCI. Amyloid deposition started in the precuneus and the frontal and temporal regions in early MCI, ultimately reaching the maximum burden in advanced MCI.
Conclusion: Our results indicate that brain perfusion deficits and beta-amyloid deposition in AD follow different trajectories that can be successfully traced using dual-phase (18)F-AV-45 PET imaging.
Keywords: 18F-Florbetapir (AV-45/Amyvid); Alzheimer’s disease; Amyloid; Dementia; Dual-phase scan; Mild cognitive impairment; Perfusion deficits.
Similar articles
-
Beta-amyloid deposition and cognitive function in patients with major depressive disorder with different subtypes of mild cognitive impairment: (18)F-florbetapir (AV-45/Amyvid) PET study.Eur J Nucl Med Mol Imaging. 2016 Jun;43(6):1067-76. doi: 10.1007/s00259-015-3291-3. Epub 2016 Jan 7. Eur J Nucl Med Mol Imaging. 2016. PMID: 26739329
-
Comparison of imaging biomarkers for Alzheimer's disease: amyloid imaging with [18F]florbetapir positron emission tomography and magnetic resonance imaging voxel-based analysis for entorhinal cortex atrophy.Int J Geriatr Psychiatry. 2015 May;30(5):505-13. doi: 10.1002/gps.4173. Epub 2014 Jul 7. Int J Geriatr Psychiatry. 2015. PMID: 25043833
-
18F-FDG Is a Superior Indicator of Cognitive Performance Compared to 18F-Florbetapir in Alzheimer's Disease and Mild Cognitive Impairment Evaluation: A Global Quantitative Analysis.J Alzheimers Dis. 2019;70(4):1197-1207. doi: 10.3233/JAD-190220. J Alzheimers Dis. 2019. PMID: 31322568
-
Positron emission tomography radiopharmaceuticals for imaging brain Beta-amyloid.Semin Nucl Med. 2011 Jul;41(4):283-99. doi: 10.1053/j.semnuclmed.2011.02.005. Semin Nucl Med. 2011. PMID: 21624562 Review.
-
Applications of amyloid, tau, and neuroinflammation PET imaging to Alzheimer's disease and mild cognitive impairment.Hum Brain Mapp. 2019 Dec 15;40(18):5424-5442. doi: 10.1002/hbm.24782. Epub 2019 Sep 14. Hum Brain Mapp. 2019. PMID: 31520513 Free PMC article. Review.
Cited by
-
Unique regional patterns of amyloid burden predict progression to prodromal and clinical stages of Alzheimer's disease.Neurobiol Aging. 2021 Oct;106:119-129. doi: 10.1016/j.neurobiolaging.2021.06.014. Epub 2021 Jun 21. Neurobiol Aging. 2021. PMID: 34284259 Free PMC article.
-
Associations of [18F]-APN-1607 Tau PET Binding in the Brain of Alzheimer's Disease Patients With Cognition and Glucose Metabolism.Front Neurosci. 2020 Jun 30;14:604. doi: 10.3389/fnins.2020.00604. eCollection 2020. Front Neurosci. 2020. PMID: 32694971 Free PMC article.
-
Dual-phase amyloid PET: hitting two birds with one stone.Eur J Nucl Med Mol Imaging. 2016 Jul;43(7):1300-3. doi: 10.1007/s00259-016-3393-6. Epub 2016 Apr 23. Eur J Nucl Med Mol Imaging. 2016. PMID: 27105874 No abstract available.
-
Association Between Lack of Insight and Prefrontal Serotonin Transporter Availability in Antipsychotic-Free Patients with Schizophrenia: A High-Resolution PET Study with [11C]DASB.Neuropsychiatr Dis Treat. 2021 Oct 21;17:3195-3203. doi: 10.2147/NDT.S336126. eCollection 2021. Neuropsychiatr Dis Treat. 2021. PMID: 34707358 Free PMC article.
-
Decreased Cerebral Amyloid-β Depositions in Patients With a Lifetime History of Major Depression With Suspected Non-Alzheimer Pathophysiology.Front Aging Neurosci. 2022 May 26;14:857940. doi: 10.3389/fnagi.2022.857940. eCollection 2022. Front Aging Neurosci. 2022. PMID: 35721010 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical